Filed (PHiled). Greater than 1-2 years since publication

Acute treatment of critical vascular stenoses with a bioabsorbable magnesium scaffold in infants with CHDs

Peter A. Zartner, Dietmar Schranz, Nathalie Mini, Martin B. Schneider, Katja SchneiderUniversity Hospital. University Giessen and Marburg. Marienhospital.Germany Cardiology in the YoungCardiol Young 2020; 30: 493-499DOI: 10.1017/S1047951120000384 AbstractBackground: Post-operative severe vascular stenosis and proliferating endothelial tissue lead to severe circulatory disorders and impair organ perfusion. Bioabsorbable magnesium scaffolds may help to overcome these obstructions without leaving obstructing […]

Acute treatment of critical vascular stenoses with a bioabsorbable magnesium scaffold in infants with CHDs Read More »

Changes in Prognosis of Heterotaxy Syndrome Over Time

Puja Banka, Adi Adar, Barbara Schaetzle, Lynn A. Sleeper, Sitaram Emani, Tal GevaBoston Children’s Hospital and Harvard University.United States PediatricsPediatrics 2020; 146: DOI: 10.1542/peds.2019-3345 AbstractBackground: Long-term outcomes in heterotaxy syndrome (HS) are poorly described. Some reports suggest improved survival in the recent era, whereas others do not. We sought to describe long-term outcomes and assess whether outcomes

Changes in Prognosis of Heterotaxy Syndrome Over Time Read More »

Trans-Right-Ventricle and Transpulmonary MicroRNA Gradients in Human Pulmonary Arterial Hypertension

Philippe Chouvarine, Jonas Geldner, Roberto Giagnorio, Ekatrina Legchenko, Harald Bertram, Georg HansmannHannover Medical School.Germany Pediatric Critical Care MedicinePediatr Crit Care Med 2020; 21: 340-349DOI: 10.1097/PCC.0000000000002207 AbstractObjectives: We investigated whether concentrations of circulating microRNAs differ across the hypertensive right ventricle and pulmonary circulation, and correlate with hemodynamic/echocardiographic variables in patients with pulmonary arterial hypertension versus nonpulmonary arterial hypertension

Trans-Right-Ventricle and Transpulmonary MicroRNA Gradients in Human Pulmonary Arterial Hypertension Read More »

Left hypoplastic lung and hemoptysis-rare familial unilateral pulmonary vein atresia

Ronly Har-Even Cohn, Matthew Hicks, Atilano Lacson, Anne HicksUniversity of Alberta.Canada Clinical Case ReportsClin Case Rep 2020; 8: 1698-1703DOI: 10.1002/ccr3.2982 AbstractUnilateral pulmonary vein atresia (UPVA) is a rare congenital vascular malformation with obliteration of the pulmonary vein. We present a case series of three siblings with variable presentation of UPVA. We suggest a dominant genetic cause based on different paternity.

Left hypoplastic lung and hemoptysis-rare familial unilateral pulmonary vein atresia Read More »

Transcatheter Recanalization of Atretic Pulmonary Veins in Infants and Children

Jay D. Patel, Mansi Mandhani, Rosemary Gray, Joelle Pettus, Courtney E. McCracken, Amanda Thomas, Holly Bauser-Heaton, Dennis W. Kim, Christopher J. PetitEmory University and Children’s Healthcare of Atlanta. Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Morgan Stanley Children’s Hospital.United States Circulation Cardiovascular InterventionsCirc Cardiovasc Interv 2022; 15: DOI: 10.1161/CIRCINTERVENTIONS.121.011351 AbstractBackground: Pulmonary vein stenosis is a progressive disease associated with a high rate of mortality in children. If left untreated, myofibroblastic proliferation

Transcatheter Recanalization of Atretic Pulmonary Veins in Infants and Children Read More »

Scimitar syndrome: A new multipatch technique and incidence of postoperative pulmonary vein obstruction

Robert L. Geggel, Kimberlee Gauvreau, Ryan Callahan, Eric N. Feins, Christopher W. BairdBoston Children’s Hospital and Harvard Medical School.United States Journal of Thoracic and Cardiovascular Surgery TechniquesJTCVS Tech 2020; 4: 208-216DOI: 10.1016/j.xjtc.2020.07.027 AbstractObjective: A review of our center’s experience before March 2011 showed that one half of 36 patients who had a baffling or reimplantation procedure to

Scimitar syndrome: A new multipatch technique and incidence of postoperative pulmonary vein obstruction Read More »

Long-term outcome of percutaneous intervention for pulmonary vein stenosis after pulmonary vein isolation procedure

Patcharapong Suntharos, Sarah E. Worley, Wei Liu, Marion Siperstein, Lourdes R. PrietoNicklaus Children’s Hospital. Cleveland Clinic Foundation. United States Catheterization and Cardiovascular InterventionsCatheter Cardiovasc Interv 2020; 95: 389-397DOI: 10.1002/ccd.28628 AbstractObjectives: Report long-term outcomes of percutaneous intervention in patients with pulmonary vein stenosis (PVS) after pulmonary vein isolation (PVI) from a single center over 16 years.Background: Outcome reports of

Long-term outcome of percutaneous intervention for pulmonary vein stenosis after pulmonary vein isolation procedure Read More »

Diagnostic performance of CT angiography to detect pulmonary vein stenosis in children

Christian A. Barrera, David Saul, Jordan B. Rapp, Christopher L. Smith, Ammie M. White, David M. Biko, Hansel J. OteroThe Children’s Hospital of Philadelphia and University of Pennsylvania.United States International Journal of Cardiovascular ImagingInt J Cardiovasc Imaging 2020; 36: 141-147DOI: 10.1007/s10554-019-01693-8 AbstractTo assess the diagnostic efficiency of CT angiography (CTA) to detect pulmonary vein stenosis in

Diagnostic performance of CT angiography to detect pulmonary vein stenosis in children Read More »

Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis

Ryan Callahan, Jesse J. Esch, Grace Wang, Christina M. Ireland, Kimberlee Gauvreau, Kathy J. JenkinsBoston Children’s Hospital and Harvard Medical School.United States Pediatric CardiologyPediatr Cardiol 2020; 41: 282-289DOI: 10.1007/s00246-019-02253-6 AbstractEvaluate the efficacy of systemic sirolimus (rapamycin) in preventing in-stent stenosis (ISS) in pediatric intraluminal pulmonary vein stenosis (PVS). Report the adverse events related to sirolimus therapy.

Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis Read More »

Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension

Kathy J. Jenkins, Jeffrey R. FinemanBoston Children’s Hospital. University of California, San Francisco.United States ChildrenChildren 2022; 9: DOI: 10.3390/children9060799 AbstractPulmonary vein stenosis (PVS) is a rare and poorly understood condition that can be classified as primary, acquired, status-post surgical repair of PVS, and/or associated with developmental lung disease. Immunohistochemical studies demonstrate that obstruction of the large

Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension Read More »

Scroll to Top